InvestSMART

EBR Systems Inc (ASX: EBR) - Announcements

Current share price for EBR : $0.125 0.005 (4.17%)+

ASX company news and announcements for EBR Systems Inc (EBR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All EBR Systems Inc (EBR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than EBR Systems Inc (EBR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for EBR Systems Inc (EBR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$106 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2024 8:40AM $0.730 $0.125 fallen by 82.88%
$106 Notification of cessation of securities - EBR 16 Jan 2024 8:47AM $0.715 $0.125 fallen by 82.52%
$106 Notification regarding unquoted securities - EBR 11 Jan 2024 5:46PM $0.645 $0.125 fallen by 80.62%
$106 Notification regarding unquoted securities - EBR 12 Dec 2023 1:41PM $0.555 $0.125 fallen by 77.48%
$106 Application for quotation of securities - EBR 11 Dec 2023 9:13AM $0.590 $0.125 fallen by 78.81%
$106 Notification of cessation of securities - EBR 11 Dec 2023 9:11AM $0.590 $0.125 fallen by 78.81%
$106 EBR Systems Investor Roadshow 1 Dec 2023 10:28AM $0.590 $0.125 fallen by 78.81%
$106 Appendix 3Y 28 Nov 2023 9:44AM $0.595 $0.125 fallen by 78.99%
$106 Application for quotation of securities - EBR 27 Nov 2023 10:24AM $0.610 $0.125 fallen by 79.51%
$106 Appendix 3Y 23 Nov 2023 10:31AM $0.630 $0.125 fallen by 80.16%
$106 Notice under ASX Listing Rule 3.10A 15 Nov 2023 9:50AM $0.790 $0.125 fallen by 84.18%
$106 CEO Healthcare Conference Presentation 15 Nov 2023 9:41AM $0.790 $0.125 fallen by 84.18%
$106 Update on Submission of Final Module to FDA 15 Nov 2023 9:37AM $0.790 $0.125 fallen by 84.18%
$106 Notification of cessation of securities - EBR 26 Oct 2023 9:48AM $0.660 $0.125 fallen by 81.06%
$106 Notification regarding unquoted securities - EBR 24 Oct 2023 9:37AM $0.680 $0.125 fallen by 81.62%
$106 Quarterly Activities/Appendix 4C Cash Flow Report 23 Oct 2023 9:25AM $0.715 $0.125 fallen by 82.52%
$106 Application for quotation of securities - EBR 26 Sep 2023 11:58AM $0.740 $0.125 fallen by 83.11%
$106 Notification of cessation of securities - EBR 20 Sep 2023 11:06AM $0.820 $0.125 fallen by 84.76%
$106 Notification regarding unquoted securities - EBR 15 Sep 2023 8:17AM $0.840 $0.125 fallen by 85.12%
$106 EBR Appoints Gary Doherty as CFO 11 Sep 2023 9:09AM $0.850 $0.125 fallen by 85.29%
$106 Positive Results from the SOLVE-CRT Randomised Sub-Study 4 Sep 2023 8:54AM $0.930 $0.125 fallen by 86.56%
$106 EBR Half Year Results 2023 and Securityholder Update 29 Aug 2023 9:45AM $0.835 $0.125 fallen by 85.03%
$106 Appendix 4D and Half Year Report & Accounts 29 Aug 2023 9:40AM $0.835 $0.125 fallen by 85.03%
$106 Notification of cessation of securities - EBR 21 Aug 2023 8:28AM $0.835 $0.125 fallen by 85.03%
$106 Notification regarding unquoted securities - EBR 16 Aug 2023 1:14PM $0.850 $0.125 fallen by 85.29%

276 - 300 of 513 results

Page 12 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.